| Rheumatoid Arthritis |
1 |
1 |
| Glucocorticoid |
0 |
0.99 |
| Cardiovascular Risk Management |
0 |
0.98 |
| Hypertension |
0 |
0.79 |
| Cardiometabolic Risk Factors |
0 |
0.66 |
| Heart Failure (HF) |
0 |
0.55 |
| Cerebrovascular Accident |
0 |
0.49 |
| Myocardial Infarction (MI) |
0 |
0.36 |
| Medicare |
0 |
0.21 |
| Tobacco Cessation |
0 |
0.21 |
| Biologic Therapy |
0 |
0.18 |
| Heart |
0 |
0.18 |
| Congestive Heart Failure |
0 |
0.17 |
| Arthritis |
0 |
0.15 |
| Disease-Modifying Antirheumatic Drugs |
0 |
0.15 |
| Revenue and Practice Management |
0 |
0.12 |
| Infarction |
0 |
0.09 |
| Steroids |
0 |
0.09 |
| Acute Myocardial Infarction (MI) |
0 |
0.08 |
| Myocardial Infarction (MI) History |
0 |
0.08 |
| Tobacco Use |
0 |
0.08 |
| Insurance |
0 |
0.06 |
| Lipids Management |
0 |
0.06 |
| Michigan |
0 |
0.06 |
| Pain Management |
0 |
0.06 |
| Antihypertensive Agents |
0 |
0.03 |
| Artery |
0 |
0.03 |
| Blood |
0 |
0.03 |
| Cardiac Arrest |
0 |
0.03 |
| Cardiovascular disease |
0 |
0.03 |
| Grant |
0 |
0.03 |
| Hyperlipidemia |
0 |
0.03 |
| Informed Consent |
0 |
0.03 |
| Office Visits |
0 |
0.03 |
| Pain |
0 |
0.03 |
| Peer Review |
0 |
0.03 |
| Pennsylvania |
0 |
0.03 |
| Percutaneous Coronary Intervention |
0 |
0.03 |
| Quality of Life |
0 |
0.03 |
| Residency |
0 |
0.03 |
| Rheumatic Disease |
0 |
0.03 |
| Transient Ischemic Attack |
0 |
0.03 |
| Wisconsin |
0 |
0.03 |